LATS2 and breast carcinoma: Finally, investigation of the biological function of LATS2 in breast cancer revealed that the siRNA-induced knockdown of LATS2 enhanced the proliferation and migration of breast cancer cells (Fig. 7a, b), indicating that LATS2 was also a tumor suppressor in breast cancer.